Abstract
Spinal cord injury (SCI) patients are at high risk of developing cystitis, and vesical neoplasia. As abnormal growth regulation of urothelium may be a predisposing factor for cystitis and vesical neoplasia, we studied alterations if any, in the expression and localization of epidermal growth factor receptor (EGRF) in the vesical urothelium by an immuno-histochemical technique, using monoclonal mouse anti-human epidermal growth factor receptor antibody (DAKO-EGFR1) in cold-cup biopsies taken from the trigone of the urinary bladder in 18 adult SCI patients who had a neuropathic bladder. Abnormal localisation of EGFR-p, i.e. cytoplasmic, was noted in 13 patients. A linear localization of EGFR-p along the cell membrane of the urothelium, considered as an essential requirement for effective function, was observed in only three cases. Combined cytoplasmic and cell membrane location of EGFR-p was seen in two patients. The three patients with cell membrane location of EGFR-p showed a strong expression of EGFR-p (2 +, 2-3 +, and 4 +, respectively); the intensity of EGFR-p expression in cases of cytoplasmic immunostaining varied considerably. Histopathology revealed denuding cystitis in one; follicular cystitis in four; active inflammatory infiltrate in three; lymphocytic infiltrate in three; squamous metaplasia in six; and intestinal metaplasia in three biopsy specimens.
The three specimens showing cell membrane location of EGFR-p were from patients who did not have an indwelling urethral catheter (a paraplegic man practising intermittent self-catheterisation, a tétraplégie patient on penile condom drainage, and a tétraplégie woman with reflex voiding), and histopathology revealed very little inflammatory infiltrate. In contrast, the biopsies from all the nine patients, who were on indwelling urethral catheter drainage and in whom the bladder biopsy revealed varying degree of cystitis, showed only cytoplasmic location of EGFR-p. Similarly, the biopsies from patients with bladder stone (n = 6) showed only cytoplasmic localisation of EGFR-p. In conclusion, abnormalities in vesical urothelial expression in EGFR in SCI patients may play a role in the pathogenesis of cystitis, vesical urothelial metaplasia, dysplasia and neoplasia.
Similar content being viewed by others
Article PDF
References
See W A . Commentary on growth factors: The bread-and-butter cytokines of urology. Journal of Urology 1994: 152: 1942.
Carpenter G, Cohen S . Epidermal growth factor. Minireview. The Journal of Biological Chemistry 1990; 265: 7709–7712.
Messing E M . Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Research 1990; 50: 2530–2537.
Messing E M, Hanson P, Ulrich P, Erturk E . Epidermal growth factor – Interactions with normal and malignant urothelium. in vivo and in situ studies. Journal of Urology 1987; 138: 1329–1335.
van Velzen et al. Vesical urothelial proliferation in spinal cord injury patients: an immunohistochemical study of PCNA and MIB-1 labelling. Paraplegia 1995; 33: 523–529.
Duel B P, Freeman M, Atala A . Expression of heparin-binding epidermal growth factor-like factor mRNA in a new model of urothelial injury. Journal of Urology 1995; 153: 265A.
Freeman M R et al. Human urothelial cells secrete and are regulated by heparin-binding epidermal growth factor-like factor. Journal of Urology 1995; 153: 307A.
Tobin M S et al. Growth factor biology of human uroepithelial cells grown under serum-free conditions. Journal of Urology 1995; 153:406A.
Bejany D E, Lockhart J L, Rhamy R K . Malignant vesical tumours following spinal cord injury. Journal of Urology 1987; 138: 1390–1392.
Dougall W C et al. Th. neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 1994; 9: 2109–2123.
Modjtahedi H et al. Antitumour activity of combination of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor. Cell Biophys 1993; 22: 129–146.
Dong Z, Fidler I, Dinney C . Bladder cancer growth inhibition by epidermal growth factor receptor tyrosine kinase inhibitors. Journal of Urology 1994; 151: 392A.
Levitzki A, Gazit A . Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267: 1782–1788.
Yi E S et al. Keratinocyte growth factor causes proliferation of urothelium in vivo. Journal of Urology 1995; 154: 1566–1570.
Gibbs J B, Oliff A . Pharmaceutical research in molecular oncology. Cell 1994; 79: 193–198.
Grizzle W E, Myers R B, Arnold M M, Srivastava S . Evaluation of biomarkers in breast and prostate cancer. Journal of Cellular Biochemistry, Supplement 1994; 19: 259–266.
Carpenter G . Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 1987; 56: 881–914.
Yamaguchi K, Carr B I, Nalesnik M A . Concomitant and isolated expression of TGF-alpha and EGF-R in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma. J Surg Oncol 1995; 58: 240–245.
Suarez-Quian C A, Byers S W . Redistribution of epidermal growth factor receptor as a function of cell density, cell-cell adhesion and calcium in human (A-431) cells. Tissue-Cell 1993; 25: 1–17.
Oguey D, Reichen J, Marti U . Differential effect of micronodular and biliary cirrhosis on epidermal growth factor receptor expression in the rat. Journal of Hepatology 1994; 21: 997–1005.
Hobert M, Carlin C . Cytoplasmic juxtamembrane domain of the human EGF receptor is required for basolateral localization in MDCK cells. J Cell Physiol 1995; 162: 434–446.
Zschiesche W, Schonborn I, Minguillon C, Spitzer E . Significance of immunohistochemical c-erbB-2 product localization pattern for prognosis of primary human breast cancer. Cancer-Lett 1994; 81: 89–94.
Sorscher S M, Green M R, Feramisco J R . Enhanced E-cadherin expression in epidermal growth factor receptor expressing cells. Biochemical and Biophysical Research Communications 1995; 206: 518–524.
Good M J et al. Localization and quantification of epidermal growth factor receptors on single cells by confocal laser scanning microscopy. The Journal of Histochemistry and Cytochemistry 1992; 40: 1353–1361.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Velzen, D., Krishnan, K., Parsons, K. et al. Epidermal growth factor receptor in the vesical urothelium of paraplegic and tetraplegic patients: an immunohistochemical study. Spinal Cord 34, 578–586 (1996). https://doi.org/10.1038/sc.1996.103
Issue Date:
DOI: https://doi.org/10.1038/sc.1996.103